| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 1st Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2025 4th Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2025 3rd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2025 2nd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2025 AMENDED |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2025 1st Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2024 4th Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2024 3rd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2024 2nd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — |